Skip to main content
. 2022 Jun 21;12:926363. doi: 10.3389/fcimb.2022.926363

Table 2.

Different PLGA NPFs that have been used for inhibition of bacterial biofilm-associated oral disorders.

Year of publication(Reference) Active Substance Drug-platform Encapsulation Method Microorganism Outcomes
2020
( Akram et al., 2021 )
Chlorhexidine Chlorhexidine-loaded mesoporous silica NPs modified with PLGA Sol-gel technique Streptococcus mutans The modified NPs with PLGA showed more profound anti-biofilm properties against S. mutans.
2019
( Mahmoud et al., 2019a )
BAR (SspB Adherence Region) 10:90 PLGA/polyethylene oxide Polymeric electrospun fibers. 3 Porphyromonas gingivalis, Streptococcus gordonii This formulation suppressed the biofilm formation and disrupted the established dual-species biofilms.
2020
( Arafa et al., 2020 )
CIP CIP-PLGA NPs, CIP-PLGA NPs coated with chitosan Double-emulsion solvent evaporation technique Enterococcus faecalis CIP-PLGA NPs coated with chitosan showed the best antibacterial and anti-biofilm effect in comparison to the CIP-PLGA NPs and CIP solution.
2020
( Sebelemetja et al., 2020 )
DVA DVA-PLGA/PEG polymeric NPs Double-emulsion (w/
o/w) method
Streptococcus mutans Decreased acid production and suppressed biofilm formation by 92%.
2018
( Fan et al., 2018 )
Ag+ and Ca2+ AgCa-PLGA submicron particles Modified water/oil/water (w/o/w) emulsification solvent evaporation method. Enterococcus faecalis,
Porphyromonas gingivalis
The synthesized NPs (by ultrasonic activation) suppressed the colonization of P. gingivalis and E. faecalis on dentin.
2018
( Mahmoud et al., 2018 )
BAR (SspB Adherence Region) BAR-encapsulated PLGA and mPEG-PLGA NPs Double-emulsion technique Porphyromonas gingivalis, Streptococcus gordonii These NPs effectively reduced the biofilm formation and eliminated the preformed biofilm.
2017
( Li et al., 2017 )
AMP (KSL-W) KSL-W-loaded PLGA/chitosan composite microspheres Electrospraying and combined crosslinking-emulsion methods Fusobacterium nucleatum These NPs showed prolonged antibacterial and inhibitory effects.
2017
( Kalia et al., 2017 )
BAR (SspB Adherence Region) BAR-modified PLGA NPs Oil-in-water (o/w) single-emulsion technique Porphyromonas gingivalis,
Streptococcus gordonii
These NPs more effectively suppressed the P. gingivalis/S. gordonii adherence and biofilm formation in comparison to the equimolar amount of free peptide.
2017
( Freire et al., 2017 )
Antiserum against DNABII family (anti-DNABII) Anti-DNABII/PLGA microsphere Modified double-emulsion technique Aggregatibacter actinomycetemcomitans These NPs increased the immune system ability to eliminate the bacterial biofilm.
2021
( Geremias et al., 2021 )
Tea tree oil and
furan-2(5H)-one.
PLGA electrospun membranes incorporated with tea tree oil and
furan-2(5H)-one
Electrospraying Streptococcus mutans Results indicated a remarkable decrease in bacterial adherence on
the synthesized membranes.
2019
( Mahmoud et al., 2019b )
Peptide (BAR) derived from Streptococcus gordonii Peptide-Modified PLGA NPs Single-emulsion
technique
Porphyromonas gingivalis These NPs inhibited the P. gingivalis colonization, biofilm formation, and bacterial virulence in a mouse model of periodontitis.

NPs, nanoparticles; CIP, ciprofloxacin; DVA, Dodonaea viscosa var. angustifolia; PEG, poly ethylene glycol; mPEG, methoxy-polyethylene glycol; AMP, antimicrobial peptide; PLGA, poly (lactide co-glycolide).